Print

Argos Therapeutics, Inc. to Present at the Stifel Nicolaus 2012 Healthcare Conference  
9/5/2012 9:46:18 AM

DURHAM, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today that Jeff Abbey, President and Chief Executive Officer, is scheduled to present at the Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel in Boston.
//-->